Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1673.55
4.35 (0.26%)
< Home < Back

Sun Pharmaceutical Industries informs about press release

Date: 10-02-2023
Sun Pharmaceutical Industries has informed that it enclosed Press Release relating to US FDA approval for generic Lenalidomide capsules.

The above information is a part of company’s filings submitted to BSE.